As a consequence of this immune activation, the tumor microenvironment becomes enriched with pro-inflammatory cytokines, such as interleukin-2 (IL-2), interleukin-6 (IL-6), interferon gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α). The gene discussed is IL2; the disease is neoplasm.